Showing results (31-40 of 96) with videos related to

Sort By:
Pageof 10
Cancer Research|March 15, 2008
Cancer-associated transforming growth factor beta type II receptor gene mutant causes activation of bone morphogenic protein-Smads and invasive phenotypeSavita Bharathy, Wen Xie, Jonathan M Yingling, et al.
The Journal of Biological Chemistry|July 24, 2003
Insulin-like growth factor-I inhibits transcriptional responses of transforming growth factor-beta by phosphatidylinositol 3-kinase/Akt-dependent suppression of the activation of Smad3 but not Smad2Kyung Song, Susan C Cornelius, Michael Reiss, et al.
Medical Image Computing and Computer-Assisted Intervention : MICCAI ... International Conference on Medical Image Computing and Computer-Assisted Intervention|November 30, 2007
A clinically motivated 2-fold framework for quantifying and classifying immunohistochemically stained specimensBonnie Hall, Wenjin Chen, Michael Reiss, et al.
The Journal of Biological Chemistry|February 26, 2004
Transforming growth factor-beta 1 regulation of collagenase-3 expression in osteoblastic cells by cross-talk between the Smad and MAPK signaling pathways and their components, Smad2 and Runx2Nagarajan Selvamurugan, Sukyee Kwok, Tamara Alliston, et al.
Cancer Informatics|December 17, 2008
Decentralized data sharing of tissue microarrays for investigative research in oncologyWenjin Chen, Cristina Schmidt, Manish Parashar, et al.
Nature Protocols|May 19, 2023
Spiral volumetric optoacoustic tomography for imaging whole-body biodynamics in small animalsSandeep Kumar Kalva, Xosé Luís Deán-Ben, Michael Reiss, et al.
Photoacoustics|April 7, 2023
Head-to-tail imaging of mice with spiral volumetric optoacoustic tomographySandeep Kumar Kalva, Xosé Luís Deán-Ben, Michael Reiss, et al.
Chaos, Solitons, and Fractals|November 3, 2025
Prediction of excitable wave dynamics using machine learningMahesh Kumar Mulimani, Sebastian Echeverria-Alar, Michael Reiss, et al.
The Journal of Biological Chemistry|October 23, 2001
Betaglycan inhibits TGF-beta signaling by preventing type I-type II receptor complex formation. Glycosaminoglycan modifications alter betaglycan functionOliver Eickelberg, Michael Centrella, Michael Reiss, et al.
Experimental Cell Research|August 28, 2007
Promoter-independent regulation of vimentin expression in mammary epithelial cells by val(12)ras and TGFbetaBradley Yates, Craig Zetterberg, Vaishali Rajeev, et al.
Pageof 10